perillaldehyde has been researched along with Reperfusion Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, B; Shi, E; Zheng, W | 1 |
| Fu, Q; Li, Y; Ma, S; Xu, L | 1 |
2 other study(ies) available for perillaldehyde and Reperfusion Injury
| Article | Year |
|---|---|
Perillaldehyde Alleviates Spinal Cord Ischemia-Reperfusion Injury Via Activating the Nrf2 Pathway.
Topics: Animals; Monoterpenes; NF-E2-Related Factor 2; Rats; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia | 2021 |
Perillaldehyde attenuates cerebral ischemia-reperfusion injury-triggered overexpression of inflammatory cytokines via modulating Akt/JNK pathway in the rat brain cortex.
Topics: Animals; bcl-2-Associated X Protein; Brain Injuries; Brain Ischemia; Caspase 3; Cytokines; Disease Models, Animal; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Male; MAP Kinase Signaling System; Monoterpenes; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Tumor Necrosis Factor-alpha | 2014 |